Comment on: 'Quantification of anterior chamber reaction after intravitreal injections of conbercept and ranibizumab: a pilot study'

Eye (Lond). 2020 Aug;34(8):1482-1484. doi: 10.1038/s41433-019-0657-y. Epub 2019 Oct 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angiogenesis Inhibitors* / adverse effects
  • Anterior Chamber
  • Humans
  • Intravitreal Injections
  • Pilot Projects
  • Ranibizumab*
  • Recombinant Fusion Proteins

Substances

  • Angiogenesis Inhibitors
  • Recombinant Fusion Proteins
  • KH902 fusion protein
  • Ranibizumab